(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

B BIOIBERICA

This trademark appears in the official USPTO history.

Even when the status is closed, the history helps calibrate risk, avoid repeating mistakes, and define a safe naming strategy.

NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILEDType: CombinedOffice: United States

Quick snapshot

B BIOIBERICA

ST13

US500000079260058

Class

1, 5

Filing

79260058

Registration

6044582

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED

Case type

Application and registration

Recorded events

50

Latest update

08/17/2026

Trademark type

Combined

Nice classes

1, 5

Filing date

12/10/2018

Registration date

05/05/2020

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

08/17/2026

Last transaction

08/17/2026

Responsible office

United States Patent and Trademark Office

Status code

739

Official register

Principal Register

Drawing code

3

Owner type

99

Owner location

PALAFOLLS, ES

Examiner

BICE, DANIEL TRAVIS

Current location

Historical data usage

Mark description

The mark consists of the white letter "B" in lower case stylized font inside of a blue carrier circle. To the right of the aforementioned letter "B" is the blue wording "BIOIBERICA" in stylized font

Holders and representatives

Holders

BIOIBERICA, S.A.U.
BIOIBERICA, S.A.U.

Representatives

LEIGH ANN LINDQUIST SUGHRUE MION, PLLC

Technical classification

Nice Classes

Class 1Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Chemical products in the nature of chemical preparations for use in industry; chemicals in the nature of chemical preparations for preserving foodstuffs; chemical products in the nature of active chemical ingredients used for the manufacture of drugs for the treatment of liver and intestinal functionalityimmunological healthcystitisosteoarthritisjoint health problems and dermatology; chemical products in the nature of chemical preparations for use in agriculture except fungicidesherbicidesinsecticides and parasiticides; chemical products in the nature of chemical preparations used for horticulture except fungicidesherbicidesinsecticides and parasiticides; chemical products used for keeping fresh and preserving foodstuffs; chemical products used for preserving and conserving foodstuffs; active chemical ingredients for use in the manufacture of pharmaceutical substances for the treatment of osteoarthritismusculoskeletal disordersthromboembolism and hypothyroidism; antioxidants for manufacturing food supplements; antioxidants for use in the manufacture of food supplements; proteins for manufacturing food supplements; vitamins for the manufacture of food supplements; chemical fertilizers; fertilizers; chemical products in the nature of chemical preparations used in agriculturehorticulture and forestry except fungicidesherbicidesinsecticides and parasiticides; chemicals products in the nature of active chemical ingredients and solvents used for the manufacture of insecticides; wetting agents for use with agrochemical products

Class 5

Pharmaceutical and veterinary preparations for treatment of liver and intestinal functionalityimmunological healthcystitisosteoarthritisjoint health problems and dermatology; dietetic substances in the nature of foodsbeveragessugarinfusions adapted for medical use; food for babies; medicinal food supplements; dietetic food supplements for humans; dietetic foods for medical use; mineral preparations for medical purposes and mineral supplements for medical purposes; protein-based food supplements; dietary supplements for medical purposes consisting of amino acids; amino acids for medical use; dietary supplements consisting of proteins; veterinary products and substances adapted for veterinary usedietetic foodsdietetic beveragesvaccinesveterinary pharmaceutical preparations in the nature of tabletsspraysfeeds and powders for the prevention and treatment of liver and intestinal functionalityimmunological healthcystitisosteoarthritisjoint health problems and dermatology; dietetic substances for veterinary usefoodsbeverages; nutritional supplements; products in the nature of preparations for destroying verminfungicides and herbicides; products in the nature of dietary pet supplements in the form of pet treats adapted for veterinary use specially for attracting pets

Publications

History of USPTO decisions and trademark events.

50 publications found

NA75

NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED

08/17/2026

C75A

REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.

08/17/2026

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

08/10/2026

ES75

TEAS SECTION 71 & 15 RECEIVED

04/29/2026

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

05/05/2025

NREP

NEW REPRESENTATIVE AT IB RECEIVED

11/20/2021

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

10/03/2020

FICS

FINAL DISPOSITION NOTICE SENT TO IB

09/11/2020

FIMP

FINAL DISPOSITION PROCESSED

09/11/2020

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

08/05/2020

R.PR

REGISTERED-PRINCIPAL REGISTER

05/05/2020

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

02/18/2020

PUBO

PUBLISHED FOR OPPOSITION

02/18/2020

GPNX

NOTIFICATION PROCESSED BY IB

02/14/2020

RFNT

REFUSAL PROCESSED BY IB

01/31/2020

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

01/29/2020

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

01/29/2020

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

01/29/2020

ALIE

ASSIGNED TO LIE

01/16/2020

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

01/14/2020

XAEC

EXAMINER'S AMENDMENT ENTERED

01/14/2020

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

01/14/2020

GNEA

EXAMINERS AMENDMENT E-MAILED

01/14/2020

CNEA

EXAMINERS AMENDMENT -WRITTEN

01/14/2020

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

01/07/2020

GNRT

NON-FINAL ACTION E-MAILED

01/07/2020

CNRT

NON-FINAL ACTION WRITTEN

01/07/2020

XAEC

EXAMINER'S AMENDMENT ENTERED

12/16/2019

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

12/16/2019

GNEA

EXAMINERS AMENDMENT E-MAILED

12/16/2019

CNEA

EXAMINERS AMENDMENT -WRITTEN

12/16/2019

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

11/27/2019

GNRT

NON-FINAL ACTION E-MAILED

11/27/2019

CNRT

NON-FINAL ACTION WRITTEN

11/27/2019

DOCK

ASSIGNED TO EXAMINER

11/01/2019

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

10/22/2019

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

10/22/2019

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

10/22/2019

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

10/17/2019

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

10/17/2019

RFNT

REFUSAL PROCESSED BY IB

08/09/2019

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

07/19/2019

RFRR

REFUSAL PROCESSED BY MPU

07/19/2019

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

07/12/2019

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

06/28/2019

CNRT

NON-FINAL ACTION WRITTEN

06/27/2019

MAFR

APPLICATION FILING RECEIPT MAILED

06/12/2019

DOCK

ASSIGNED TO EXAMINER

06/08/2019

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

06/08/2019

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

06/06/2019

Continuous trademark protection

Get notified about every new filing that threatens B BIOIBERICA or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.